Treatment With Duloxetine for OCD Patients

Not Applicable

Withdrawn

• Conditions: OCD

• Registration Number: NCT00399022
• Lead Sponsor: Sheba Medical Center

Brief Summary

Testing the efficacy of the SNRI medication Duloxetine for treating OCD patients who did not respond to SSRI

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-11-13
• Study First Submitted QC: 2006-11-13
• Study First Posted: 2006-11-14
• Status Verified: 2008-01
• Last Update Submitted: 2008-01-28
• Last Update Posted: 2008-01-31

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• OCD as main diagnosis according to DSM-IV
• Age 18 to 65
• Men and women
• YBOCS score is 18 or more, or 12 or more in case of only obsessions

Exclusion Criteria

• Patients treated with Duloxetine, currently or in the past
• Patients having comorbid schizophrenia or psychotic disorder or bipolar disorder Patients with substance abuse disorder in the last 6 months Patients who were suicidal or did serious suicide attempt in the last year Pregnant or lactating women, or woman of childbearing potential, which is not using adequate contraception Patients with neurologic disturbance or disorder Patients with serious or imbalanced medical condition Patients with allergic response to SSRI or duloxetine Patients who started new treatment (CBT or pharmacology) in less than 3 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Chaim Sheba Medical Center; 🇮🇱 Ramat-Gan, Israel